Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 459
Immune Disorders Drugs 196
Cardiovascular Drugs 161
Drug Discovery 148
Infectious Diseases Drugs 132
Biopharmaceuticals 127
Endocrine and Metabolic Disorders Drugs 113
Clinical Trials 107
Central Nervous System Drugs 106
Musculoskeletal Disorders Drugs 98
Pharmaceuticals 95
Leukemia Drugs 82
Hematological Drugs 80
Liver and Kidney Disorders Drugs 76
Lymphoma Drugs 62
Dermatological Drugs 59
Diabetes Drugs 57
Skin Cancer Drugs 48
Brain Cancer Drugs 46
Respiratory Drugs 45
Mental Disorders Drugs 43
Lung Cancer Drugs 39
Gastrointestinal Drugs 38
Drug Delivery 36
Pharmaceutical Intermediates 35
Immunosuppressive Drugs 33
Pharmaceutical Manufacturing 31
Infusions and Injectables 30
Liver Cancer Drugs 29
Analgesics 27
Antibiotics 26
Bladder Cancer Drugs 25
Drugs by Therapeutic Area 23
Kidney Cancer Drugs 21
Pancreatic Cancer Drugs 19
HIV/AIDS Drugs 19
Prostate Cancer Drugs 18
Urological Disorders Drugs 18
Colon Cancer Drugs 17
Schizophrenia Drugs 17
Cervical Cancer Drugs 16
Sexual and Reproductive Health Drugs 16
Ovarian Cancer Drugs 15
Thyroid Cancer Drugs 14
Breast Cancer Drugs 13
Cancer Vaccines 13
Psoriasis Drugs 12
Over the Counter (OTC) Drugs 11
Biosimilars and Biosuperiors 11
Generic Drugs 10
Anti-Obesity Drugs 9
Optical Disorders Drugs 8
Transdermal and Transmucosal Drug Delivery 8
Vaccines 8
Alzheimer's Disease Drugs 7
Uterine Cancer Drugs 6
Company Reports 5
Cough and Cold Drugs 5
Anxiety Drugs 4
Pharmacoeconomics 3
Vitamins and Dietary Supplements 3
Asthma Drugs 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Allergy Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



279 reviews

2,425 Results (Page 58 of 122)
- Relevance
  Sort by

Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
December 2022
42 Pages
Global

From

€3096EUR$3,500USD£2,669GBP

Chronic Cough Market Report 2025

 Report
February 2025
200 Pages
Global

From

€3971EUR$4,490USD£3,424GBP

Fungal Keratitis Treatment - Global Strategic Business Report

 Report
August 2025
484 Pages
Global

From

€5174EUR$5,850USD£4,461GBP

Ibrutinib Market Report 2025

 Report
March 2025
200 Pages
Global

From

€3971EUR$4,490USD£3,424GBP

Metabotropic Glutamate Receptor 2 (GPRC1B or MGLUR2 or GRM2) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
October 2022
57 Pages
Global

From

€3096EUR$3,500USD£2,669GBP

NEED HELP FINDING THE RIGHT PRODUCT? Farid will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Metabotropic Glutamate Receptor 5 (GPRC1E or MGLUR5 or GRM5) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
October 2022
69 Pages
Global

From

€3096EUR$3,500USD£2,669GBP

Multiple Myeloma- Pipeline Insight, 2025

 Clinical Trials
April 2025
230 Pages
Global

From

€2654EUR$3,000USD£2,288GBP

Lymphoma Treatment Market Report by Type, Test Type, Drug, and Region 2024-2032

 Report
August 2024
146 Pages
Global

From

€2653EUR$2,999USD£2,287GBP

T-Cell Lymphoma Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2020-2030F

 Report
April 2025
182 Pages
Global

From

€3980EUR$4,500USD£3,432GBP

Diffuse Large B-Cell Lymphoma Therapeutics Market Report 2025

 Report
February 2025
200 Pages
Global

From

€3971EUR$4,490USD£3,424GBP

Follicular Lymphoma Treatment Market Report 2025

 Report
February 2025
200 Pages
Global

From

€3971EUR$4,490USD£3,424GBP

Non Hodgkin Lymphoma (NHL) Market Report 2025

 Report
February 2025
200 Pages
Global

From

€3971EUR$4,490USD£3,424GBP

Mantle Cell Lymphoma Therapeutics Market Report 2025

 Report
February 2025
200 Pages
Global

From

€3971EUR$4,490USD£3,424GBP

Asia Pacific Vulvovaginal Candidiasis Treatment Market Size, Share & Industry Trends Analysis Report By Distribution Channel, By Route of Administration (Oral, Intravenous and Topical), By Drug Class, By Country and Growth Forecast, 2022 - 2028

 Report
November 2022
82 Pages
Asia Pacific

From

€1327EUR$1,500USD£1,144GBP

North America Vulvovaginal Candidiasis Treatment Market Size, Share & Industry Trends Analysis Report By Distribution Channel, By Route of Administration (Oral, Intravenous and Topical), By Drug Class, By Country and Growth Forecast, 2022 - 2028

 Report
November 2022
71 Pages
North America

From

€1327EUR$1,500USD£1,144GBP

LAMEA Vulvovaginal Candidiasis Treatment Market Size, Share & Industry Trends Analysis Report By Distribution Channel, By Route of Administration (Oral, Intravenous and Topical), By Drug Class, By Country and Growth Forecast, 2022 - 2028

 Report
November 2022
82 Pages
Africa, Middle East

From

€1327EUR$1,500USD£1,144GBP

Europe Vulvovaginal Candidiasis Treatment Market Size, Share & Industry Trends Analysis Report By Distribution Channel, By Route of Administration (Oral, Intravenous and Topical), By Drug Class, By Country and Growth Forecast, 2022 - 2028

 Report
November 2022
82 Pages
Europe

From

€1327EUR$1,500USD£1,144GBP

Diffuse Large B-cell Lymphoma Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

 Report
March 2025
183 Pages
Global

From

€3980EUR$4,500USD£3,432GBP

Polycystic Ovarian Syndrome Treatment Market by Treatment Type, Drug Class, Route Of Administration, Distribution Channel, End User, Patient Type - Global Forecast 2025-2030

 Report
August 2025
188 Pages
Global

From

€3136EUR$3,545USD£2,703GBP

€3484EUR$3,939USD£3,004GBP

Leukemia Therapeutics Market Analysis & Forecast to 2024-2034

 Report
January 2024
200 Pages
Global

From

€3671EUR$4,150USD£3,165GBP

2,425 Results (Page 58 of 122)
- 1
- 56
- 57
- 58
- 59
- 60

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.